ZTS, US98978V1035

Zoetis stock gets USDA license for three-disease poultry vaccine

Published on 11/19/2026 at 14:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Zoetis stock gets a new poultry-health catalyst after U.S. regulators license a three-disease vaccine. The product targets major chicken diseases.

Zoetis expands poultry vaccine portfolio

  • The USDA license covers protection against Marek's disease, Newcastle disease and infectious laryngotracheitis.
  • The vaccine is intended for healthy one-day-old chickens or 18- to 19-day-old embryonated chicken eggs.
  • The approval expands Zoetis' options for poultry veterinarians and producers.
ZTS, US98978V1035, Illustration mit AI erstellt.

Zoetis said on Thursday, November 19, that the U.S. Department of Agriculture had licensed Poulvac Procerta HVT-ND-ILT, a vector vaccine designed to protect chickens against Marek's disease, Newcastle disease and infectious laryngotracheitis. The company announced the regulatory decision in a Business Wire release.

Zoetis stock traded at 77.34 euros on Lang & Schwarz at 14:00 CET on Thursday, November 19.

Three disease targets in one vaccine

The licensed product combines protection against three diseases in one vaccine. Zoetis said it is labeled for healthy one-day-old chickens and for 18- to 19-day-old embryonated chicken eggs.

The company said the vaccine gives poultry veterinarians and producers another option when developing flock-health programs. It can be included in seasonal or rotational infectious-laryngotracheitis programs that also use modified-live vaccines.

Portfolio support for poultry customers

Zoetis positioned Poulvac Procerta alongside other poultry products addressing infectious bursal disease, infectious bronchitis, Salmonella and E. coli. The company also offers technical guidance, diagnostic testing, hatchery services, training and flock-health assessments.

The license broadens the company's poultry-health portfolio, although the release did not provide sales guidance for the product.

The S&P 500 provides the broader market setting for U.S.-listed shares.

More news and analyses on Zoetis stock

Zoetis company facts

  • Company: Zoetis Inc.
  • ISIN: US98978V1035
  • Ticker: ZTS
  • Home exchange: New York Stock Exchange
  • Lang & Schwarz quote: 77.34 euros at 14:00 CET on November 19, 2026
Disclaimer...
en | US98978V1035 | ZTS | boerse | 70536133 | bgmi